Raghavan Murugan, MD, MS, FRCP, FCCM, was appointed ICU Director and Chief of Critical Care Medicine at Magee-Womens Hospital of UPMC, effective July 1. The Magee 14-bed state of the art unit admits critically ill patients from Internal Medicine and related sub-specialties including Obstetrics, Gynecology and Oncology services. Murugan is replacing David Muigai, MBChB, MMM, who left the Department of Critical Care Medicine at the end of August.
Murugan, who is an Associate Professor of Critical Care Medicine and Clinical and Translational Science, was just appointed the Director of the Rapid Response Team (RRT) at UPMC Presbyterian Hospital in July 2015. The RRT oversees more than 2000 rapid response team calls, including approximately 150 activations for cardiopulmonary arrest. It also oversees and supervises ICU care for night time critical care staff and facilitates ICU triage decisions when ICU resources are constrained.
“I am excited to begin my time as ICU Chief at Magee,” said Murugan. “Our ICUs there are state-of-the art, and the patient population is unique, frequently made up of pregnant women. Since these patients are younger than those traditionally seen in ICUs, tracking their recovery is often a satisfying and rewarding experience.”
Murugan is also currently an Attending Intensivist in the Transplant Intensive Care Unit at UPMC Montefiore, and conducts research as a core faculty member of the Center for Critical Care Nephrology, CRISMA. His translational research, which is focused on understanding mechanisms of inflammation-induced organ dysfunction after critical illness with a particular focus on acute kidney injury, has yielded more 60 peer reviewed publications.
Murugan is American Board certified in Internal Medicine and the subspecialty of Critical Care Medicine, and is an elected Fellow of the Royal College of Physicians, London, UK and the American College of Critical Care Medicine.